Bin Yao，MD

Titles

Vice Director, Department I of Endocrinology and Metabolism

Chief physician of Endocrinology and Metabolism

Professor of Endocrinology and Metabolism

Master’s advisor of Endocrinology and Metabolism

Research Interests

·Type2 diabetes mellitus and its complications

·Type1 diabetes mellitus and its complications

·Pituitary adenoma

·Thyroid gland diseases

·Osteoporosis

·Abnormal growth and development

·Other rear diseases of endocrinology and metabolism

He has been devoted himself on clinical endocrinology practice for more than 30 years. Not only is he good at treating diabetes, thyroid gland and pituitary diseases, but also does he specialize in treating rear diseases of endocrinology and metabolism. In 2012, he was appointed as Sub-Principle investigator in the STRATEGY Study, which is by far the largest national-wide type 2 diabetes mellitus clinical research in China. Since 2012, he has devoted himself to integrated management of T1DM as a group leader for type 1 diabetes research group in the hospital. For the last four years, he has given hundreds of lectures on T1DM management in lots of Chinese hospitals and also annual scientific meeting of Chinese Diabetes society.

Education and Experience

·MD, the first affiliated hospital of Sun Yat-Sen University(1987-1990)

·Residency, the first affiliated hospital of Sun Yat-Sen University(1990-2000)

·Associate professor, Master’s advisor, the first affiliated hospital of Sun Yat-Sen University(2000-2012)

·Chief physician, professor, Master’s advisor, the third affiliated hospital of Sun Yat-Sen University(from 2012 till now)

Honors and Awards

·First Class, the Award of the Chinese Ministry of Education, The experiments and clinical research on the relation of islet B cells’ functions and type2 diabetes.

·First Class of the Guangdong Science and Technology Progress Award, The basal and clinical research on the effect factors of islet B cells

·Third Class of the Guangdong Science and Technology Progress Award, Pathogenesis of type2 diabetes combined with osteoporosis

·In charge of 8 Guangdong Natural Science Funds and health science and technology funds

·International Diabetes Funds, 170 thousand euro, the management of type1 diabetes pregnancy

·More than 50 articles has been published in Chinese and Foreign Journals.

·Involved in writing Chinese guidelines for diabetes and other endocrinology diseases for more than 10 years

Publications

1.The effects of short-term continuous subcutaneous insulin infusion treatment on beta-cell function in newly diagnosed type 2 diabetic patients, 2003, Chinese Journal of Diabetes.

2.DelD631: a novel mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A)，2007，ational Medical of China.

3.Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up，2007，Chinese Journal of Internal Medicine.

4.A novel mutation (D631del) of the RET gene was associated with MEN2A in a Chinese pedigree， 2009，Endocrine Journal.

5.Novel Mutation (D631del) of the RET gene was associated with MEN2A in a Chinese Pedigree， 2009 ，Endocrine Journal.

6.Post transplantation diabetes mellitus in 1872 kidney allograft recipients during hospitalization：prevalence and risk factors. 2009，Diabetes.

7.Relationship between Vitamin D Receptor Gene Polymorphism and Post Transplantation Diabetes Mellitus，2009 ，Endocrine Journal.